Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 32Terminated 14Active not recruiting 10Recruiting 7Unknown 6Withdrawn 3Suspended 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Neoplasms 1Lung Neoplasms 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Specimen Handling 32Magnetic Resonance Spectroscopy 21Biopsy 20Cyclophosphamide 16Nivolumab 10Paclitaxel 9Cisplatin 9Gemcitabine 8Bevacizumab 8venetoclax 7Vincristine 7Prednisone 7Doxorubicin 7Azacitidine 7pembrolizumab 6Radiotherapy 6Radiosurgery 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Taxes 5Rituximab 5Oxaliplatin 5Irinotecan 5Everolimus 5Capecitabine 5fludarabine phosphate 4fludarabine 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Positron-Emission Tomography × Clear all
NCT05844306 2025-11-19

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

City of Hope Medical Center

Phase NA Suspended
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT04017819 2025-11-05

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

Stanford University

Phase 1 Suspended
20 enrolled
Thoracic

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡